President Donald Trump's recent executive order aims to split the measles, mumps, and rubella (MMR) vaccine into three separate vaccinations. However, health experts have criticized this move, stating it is based on unfounded claims and could lead to logistical challenges that may result in more missed vaccinations. Dr.
Andrew Racine, president of the American Academy of Pediatrics, highlighted that the U.S. is experiencing its highest number of measles cases in decades, partly due to a decline in parental willingness to vaccinate their children. Approximately 9% of parents are already delaying or skipping the MMR vaccine, which could worsen if Trump's proposal gains traction.
Experts like Neil Maniar from Northeastern University and William Moss from Johns Hopkins University emphasize that separating the vaccine would not solve existing issues but create new ones, complicating access and increasing the number of required doses.
Vaccine manufacturers, including Merck and GSK, have little incentive to develop standalone vaccines, as it would divert resources from other critical health initiatives. Overall, this proposal could undermine public confidence in the MMR vaccine and hinder efforts to combat the ongoing measles outbreak